Enhanced Survival Associated with Vitiligo Expression during Maintenance Biotherapy for Metastatic Melanoma
- 1 December 2006
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 126 (12), 2658-2663
- https://doi.org/10.1038/sj.jid.5700545
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prognostic Significance of Autoimmunity during Treatment of Melanoma with InterferonThe New England Journal of Medicine, 2006
- Autoimmune Aspects of Depigmentation in VitiligoJournal of Investigative Dermatology Symposium Proceedings, 2004
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Direct Evidence to Support the Role of Antigen-Specific CD8+ T Cells in Melanoma-Associated VitiligoJournal of Investigative Dermatology, 2001
- A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligoTrends in Immunology, 2001
- Autoimmune aspects of vitiligo.Autoimmunity, 2001
- Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-γ retroviral vector in melanoma patientsCancer Gene Therapy, 2000
- Advantages of Concurrent Biochemotherapy Modified by Decrescendo Interleukin-2, Granulocyte Colony-Stimulating Factor, and Tamoxifen for Patients With Metastatic MelanomaJournal of Clinical Oncology, 1999
- Antibody Responses to Melanoma/Melanocyte Autoantigens in Melanoma PatientsJournal of Investigative Dermatology, 1998
- Vitiligo in patients with metastatic melanoma: A good prognostic signJournal of the American Academy of Dermatology, 1983